Active Solicitation · DEPT OF DEFENSE
AI Summary
The Defense Health Agency is seeking industry feedback on draft documents for the next generation TRICARE Pharmacy Program contract. Qualified vendors are invited to submit comments and questions by May 22, 2026, and can request one-on-one meetings to discuss the draft documents. This opportunity is focused on healthcare services related to pharmacy management.
The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm6) contract. These draft documents are provided for industry’s feedback and refinement. The Government invites qualified vendors to submit feedback and questions on the following draft documents:
The DHA will facilitate one-on-one meetings with industry to gather additional feedback and answer questions related to the draft documents in the summer of 2026. Please follow the instructions below to request a one-on-one meeting and to submit questions, comments, or general feedback.
Instructions
Comments and questions specific to Section C and Section H must be submitted no later than May 22, 2026 at 12:00PM Mountain Time to dha.buckley.AD-SPT-CAE.mbx.tpharm6@health.mil. Include in the email subject line the following: Your Company Name and Draft Documents Response.
One-On-One Meetings: Requests for a one-on-one meeting with the DHA related to TPharm6 can be made using the link - https://forms.osi.apps.mil/r/zBn9EyRm0g. The request for one-on-one meeting attendance must be submitted no later than May 22, 2026 at 12:00PM Mountain Time.
TRICARE PHARMACY PROGRAM RFI (DRAFT SECTION C & H) is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.